Popular Articles

Lawsuit Filed Over Gene Patent
A group of cancer patients, genetic researchers and professional pathologist organizations has filed a lawsuit against Myriad Genetics and the U.S. Patent Office over the patent of two genes associated with an increased risk of breast and ovarian cancers, the New York Times reports. According to the Times, the government more than 10 years ago granted Myriad the patent on the BRCA1 and BRCA2 genes, as well as the company"s genetic test that measures a patient"s risk for the cancers.The lawsuit was filed by the American Civil Liberties Union and is believed to be the first of its kind, the Times reports. The lawsuit challenges the decision to grant patents on genes to Myriad and companies like it. The plaintiffs say that patents on genes restrict medical and research efforts, while companies like Myriad have said that the patent system supports innovation by giving them a temporary monopoly after they make a discovery, thereby rewarding prior investment in research and development.Wendy Chung, the director of clinical genetics at Columbia University and a plaintiff in the case, said, "With a sole provider, there"s mediocrity." The plaintiffs say that BRCA testing would improve with market competition. Furthermore, some plaintiffs argue that certain natural materials cannot be patented. Jan Nowak, president of the Association for Molecular Pathology and a plaintiff in the case, said, "You can"t patent my DNA, any more than you can patent my right arm, or patent my blood."To date, two government panels, including the National Research Council, found no evidence that gene patents result in significant impediments to research or medical care (Schwartz, New York Times, 5/13).
generic viagra online
USA Today Examines 'Incendiary Debate' Over Abortion Rights
Nearly 40 years after the Supreme Court"s decision in Roe v. Wade, the "incendiary debate over abortion rights endures" and continues to manifest itself in a number of ways, USA Today reports. According to a recent USA Today/Gallup Poll, 78% of U.S. residents want abortion to be legal under at least some circumstances, with 21% saying it should be legal under any circumstance. According to the poll, 18% of respondents said that they want abortion always to be illegal. The poll also found that 46% of U.S. residents self-identify as "pro-choice," while 47% self-identify as "pro-life."Nancy Northup, president of the Center for Reproductive Rights, said, "The enduring divide represents the reality that there are fundamental religious differences on the issue of abortion that do not exist on, say, campaign finance or even on health care." Americans United for Life President Charmaine Yoest said that abortion-rights opponents are mobilizing to urge congressional lawmakers to exclude abortion coverage and funding from any federal health reform legislation.During the confirmation hearings of Supreme Court nominee Sonia Sotomayor, the judge said that she does not believe previous court rulings on abortion rights have ended the national controversy surrounding the issue. According to USA Today, Sotomayor, who has never ruled on the issue, declined to reveal her personal position on abortion rights. Several antiabortion-rights advocates also protested during Sotomayor"s hearings (Biskupic, USA Today, 7/24).In addition, the Center for Reproductive Rights this week released a report that found physicians and employees of health care clinics providing abortion services in six states -- Alabama, Mississippi, Missouri, North Dakota, Pennsylvania and Texas -- face an increasing level of harassment and death threats. The report was based on a four-month investigation (AP/Houston Chronicle, 7/23). The report was tied to the murder of Kansas abortion provider George Tiller (USA Today, 7/24). Operation Save America Director the Rev. Flip Benham, whose group is mentioned in the report, said the center is trying to limit the free-speech rights of abortion-rights opponents (AP/Houston Chronicle, 7/23).
News of the day
The Cytoplasmic Talk Of Retroviruses Helps Them Spread From Cell To Cell
It is known that Retroviruses, such as HIV, that are already within cells
Health Insurance

Pioneering Research Benefits The West Midlands, UK

Top researchers from the West Midlands are working to improve the treatment of conditions that affect millions of people. Across the region research into areas such as osteoarthritis, joint pain and sciatica, stroke prevention and treatment, community care for people living with diabetes, and the treatment of liver disease have received a real boost over the last three years. The National Institute for Health Research (NIHR) is bringing together the region"s health researchers to work in partnership with the NHS. As a result there are more scientific studies now being conducted in this part of the country than ever before. More scientists - based in universities like Birmingham, Coventry and Warwick - are joining forces with local NHS trusts and patients to develop new treatments which can be translated quickly into better care. Today Professor Dame Sally C. Davies, Director General of Research and Development at the Department of Health addressed a conference of 300 health researchers from the West Midlands region where she talked about the progress that had been made since the National Institute for Health Research was launched in 2006. She also thanked them for their role in translating research activity into real benefits for patients, the public and the NHS. She said: "When we launched the NIHR, we knew what we wanted to achieve and understood what we had to do to get there. We could see the huge potential for improving, expanding and strengthening the way that health research is delivered for patients, the public and the NHS. Today"s report entitled Delivering health research explains how we are delivering the vision first set out in the Government"s health research strategy: Best Research for Best Health. By working together across the NHS, and with patients, the best health research academic institutions in the country and industry, we are delivering that promise." The aim of NIHR funded research is to find and evaluate treatments for patients across the spectrum of medical settings, so that people receive better care when they need it. The NIHR only funds studies where there is a clear link to the quality of patient care. The result is that more NHS patients are benefitting from leading edge research. The NIHR approach, which has been developed over the last three years, is helping to bring together the research community and creating more opportunities for patients to be involved in trials to develop new treatments. All of this work is highlighted in a new report published by the National Institute for Health Research, entitled Delivering Health Research. Department of Health, UK


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):